Trill Impact Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital, ESG and Impact Investing
Stage Focus
Seed, Early Stage, Series A, Series B, Growth
Geographical Focus
United States, Germany, Luxembourg, Sweden
Industries Focus
- Life Science
- Green Tech
- Impact Enablers
Investor Details Founded: 2019
Trill Impact Ventures is a venture capital firm co-leading financing rounds in companies developing novel vaccines and therapeutics, aiming to deliver real returns and lasting impact for the benefit of investors, businesses, and society at large.
The firm focuses on early-stage companies addressing environmental and health challenges, with investment themes including Green Tech, Life Science, and Impact Enablers. Their approach integrates impact measurement and management throughout the investment process, ensuring that each portfolio company contributes positively to the UN Sustainable Development Goals.
Trill Impact Ventures has a track record of backing transformative technologies needed to achieve the SDGs, partnering with some of Europe's best entrepreneurs to scale businesses with global ambitions. Their portfolio includes companies like Cinclus Pharma, MinervaX, and tado°, reflecting their commitment to impactful investments in health and environmental sectors.
Requirements
- Companies addressing environmental and health challenges
- Alignment with UN Sustainable Development Goals
- Potential for scalable impact
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Cinclus Pharma
- Minervax
- tado°
- Open Cosmos
- Soil Capital
Mentioned In
Claim this Investor
Are you an official representative of Trill Impact Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim